Clinical trials
Phase 2 Squamous Cell Carcinoma of Head and Neck trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
| Completed | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ALX Oncology Inc. | 2 |
| Gilead Sciences | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| MacroGenics | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Regeneron Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| BeiGene | 1 |
| Benitec Biopharma, Inc. | 1 |
| DualityBio Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 22 |
| Head and Neck Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Melanoma | 4 |
| Neoplasm Metastasis | 4 |
| Recurrence | 3 |
| Carcinoma, Squamous Cell | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Small Cell Lung Carcinoma | 2 |
| Anus Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.